Eyebot Announces $6M Seed Round

▤ Summary

BOSTON, MA, Eyebot, developer of cutting edge rapid point-of-sale eye prescription technologies, today announced the closing of a $6 million seed funding round. This strategic infusion of capital will bolster Eyebots product development trajectory, grow the team, and accelerate its expansion initiatives. Established in 2021, Eyebot is a deep tech company operating at the forefront of innovation in the vision care industry. Eyebot specializes in the development of self-serve, rapid vision testing technologies that deliver reliable results in a matter of seconds. Our mission is to eliminate the barriers to affordable vision care and eyewear, by transforming a process that traditionally takes weeks or months into a matter of seconds.

▦ Linked Companies